BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7830274)

  • 21. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
    Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB
    Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.
    Minor DL; Wyrick SD; Charifson PS; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1994 Dec; 37(25):4317-28. PubMed ID: 7996543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
    Doll MK; Nichols DE; Kilts JD; Prioleau C; Lawler CP; Lewis MM; Mailman RB
    J Med Chem; 1999 Mar; 42(5):935-40. PubMed ID: 10072690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.
    Michaelides MR; Hong Y; DiDomenico S; Bayburt EK; Asin KE; Britton DR; Lin CW; Shiosaki K
    J Med Chem; 1997 May; 40(11):1585-99. PubMed ID: 9171869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist.
    Kohli JD; Horn PT; Glock D; Brewster WK; Nichols DE
    Eur J Pharmacol; 1993 Apr; 235(1):31-5. PubMed ID: 8100195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
    Mottola DM; Kilts JD; Lewis MM; Connery HS; Walker QD; Jones SR; Booth RG; Hyslop DK; Piercey M; Wightman RM; Lawler CP; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1166-78. PubMed ID: 12023552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.
    Watts VJ; Lawler CP; Knoerzer T; Mayleben MA; Neve KA; Nichols DE; Mailman RB
    Eur J Pharmacol; 1993 Aug; 239(1-3):271-3. PubMed ID: 8223910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
    Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
    J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors.
    Salmi P; Ahlenius S
    Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydrexidine--the first full dopamine D1 receptor agonist.
    Salmi P; Isacson R; Kull B
    CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and preliminary pharmacological evaluation of 5-hydroxy- and 5,6-dihydroxy-1,2,3,7,12,12a-hexahydrobenzo[5,6]cyclohepta[1,2,3-ij]isoquinoline derivatives as dopamine receptor ligands.
    Cingolani GM; Di Stefano A; Napolitani F; Mosciatti B; Giorgioni G; Cinone N; Brunetti L; Luisi G; Michelotto B; Orlando G; Costa B; Lucacchini A; Martini C; Claudi F
    Bioorg Med Chem; 2001 Jun; 9(6):1447-58. PubMed ID: 11408163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, resolution, and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptors ligands.
    Claudi F; Cingolani GM; Di Stefano A; Giorgioni G; Amenta F; Barili P; Ferrari F; Giuliani D
    J Med Chem; 1996 Oct; 39(21):4238-46. PubMed ID: 8863801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
    J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
    Berger JG; Chang WK; Clader JW; Hou D; Chipkin RE; McPhail AT
    J Med Chem; 1989 Aug; 32(8):1913-21. PubMed ID: 2666667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.